| Date | Title | |
| November 28, 2007 | POZEN to Present at the RBC Capital Markets 2007 Healthcare Conference |  |
| November 26, 2007 | POZEN To Present at the BMO Capital Markets 2007 Focus on Healthcare Conference | |
| November 14, 2007 | POZEN To Present at the Lazard Capital Markets Fourth Annual Healthcare Conference | |
| November 01, 2007 | POZEN Reports Third Quarter Results | |
| November 01, 2007 | Pozen Announces Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) Amended Response Accepted for Review by FDA | |
| October 17, 2007 | POZEN Announces November 1, 2007 Webcast of Third Quarter 2007 Results | |
| October 15, 2007 | POZEN Submits Response to Approvable Letter for Trexima(TM) | |
| October 05, 2007 | POZEN Plans to Submit Response to Approvable Letter For Trexima(TM) Within the Next Ten Days | |
| September 07, 2007 | POZEN Announces September 7, 2007 Webcast | |
| September 07, 2007 | POZEN/AstraZeneca Announce Start of the PN 400 Phase III Program | |
| August 02, 2007 | Pozen Announces August 2, 2007, Webcast | |
| August 02, 2007 | FDA Issues Second Approvable Letter for Trexima (TM) | |
| July 26, 2007 | POZEN Reports Second Quarter 2007 Results | |
| July 24, 2007 | POZEN Names Dr. John G. Fort as Chief Medical Officer | |
| July 16, 2007 | POZEN Announces July 26, 2007 Webcast of Second Quarter 2007 Results | |
| July 10, 2007 | POZEN Announces Settlement Agreement in Shareholder Lawsuit | |
| June 14, 2007 | POZEN to Present at the Jefferies 2007 Healthcare Conference | |
| May 31, 2007 | POZEN to Present at the Needham Sixth Annual Biotechnology & Medical Technology Conference | |
| May 14, 2007 | POZEN To Present at Citigroup's Global Healthcare Conference | |
| May 02, 2007 | POZEN Reports First Quarter 2007 Results | |
| May 01, 2007 | POZEN to Present at the Baird 2007 Growth Stock Conference | |
| April 30, 2007 | POZEN To Present at the 2007 UBS Global Generic and Specialty Pharmaceuticals Conference | |
| April 18, 2007 | POZEN Announces May 2, 2007 Webcast of First Quarter 2007 Results | |
| April 03, 2007 | Trexima (TM) (Sumatriptan/Naproxen Sodium) Superior Efficacy Data Published in JAMA | |
| March 22, 2007 | POZEN Announces Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) Amended Response Accepted for Review by FDA | |
| March 12, 2007 | POZEN to Present at the 27th Annual Cowen & Company Healthcare Conference | |
| March 07, 2007 | POZEN Reports Fourth Quarter and Year End 2006 Results | |
| March 06, 2007 | POZEN Announces Positive Outcome for PA 325 Proof of Concept Study | |
| February 28, 2007 | POZEN To Present at the Oppenheimer Conference ''Positioning Investors for the Next Wave in Pain Management'' | |
| February 16, 2007 | POZEN To Present at the Susquehanna Financial Group Healthcare Conference | |
| February 15, 2007 | Jacques Rejeange Appointed to POZEN Board of Directors | |
| February 14, 2007 | POZEN Announces March 7 Webcast of Fourth Quarter and Full Year 2006 Results | |
| January 17, 2007 | POZEN to Present at the Wachovia Securities 2007 Small and Mid-Cap Healthcare Conference | |
| January 10, 2007 | POZEN Names Gilda M. Thomas as Senior Vice President and General Counsel | |
